世界の尿路感染症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Urinary Tract Infection Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5834 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、尿路感染症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（キノロン、ペニシリン＆組み合わせ、セファロスポリン、テトラサイクリン、スルホンアミド、ニトロフラン、その他）、用途別市場規模（病院薬局、小売薬局、Eコマース）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・尿路感染症治療薬の市場動向 ・企業の競争状況、市場シェア ・尿路感染症治療薬の種類別市場規模（キノロン、ペニシリン＆組み合わせ、セファロスポリン、テトラサイクリン、スルホンアミド、ニトロフラン、その他） ・尿路感染症治療薬の用途別市場規模（病院薬局、小売薬局、Eコマース） ・尿路感染症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・尿路感染症治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・尿路感染症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・尿路感染症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・尿路感染症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、AstraZeneca、Novartis International、Johnson & Johnson、F. Hoffmann La Roche、Teva Pharmaceutical Industries、Boehringer Ingelheim、Cipla） ・結論

Market Analysis and Insights: Global Urinary Tract Infection Therapeutics Market
The global Urinary Tract Infection Therapeutics market size is projected to reach US$ 81750 million by 2026, from US$ 71130 million in 2019, at a CAGR of 2.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Urinary Tract Infection Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Urinary Tract Infection Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Urinary Tract Infection Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Urinary Tract Infection Therapeutics market.

Global Urinary Tract Infection Therapeutics Scope and Market Size
Urinary Tract Infection Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Urinary Tract Infection Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Quinolones
Penicillin & Combinations
Cephalosporin
Tetracycline
Sulphonamides
Nitrofurans
Other

Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-Commerce

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
AstraZeneca
Novartis International
Johnson & Johnson
F. Hoffmann La Roche
Teva Pharmaceutical Industries
Boehringer Ingelheim
Cipla

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urinary Tract Infection Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Quinolones
1.2.3 Penicillin & Combinations
1.2.4 Cephalosporin
1.2.5 Tetracycline
1.2.6 Sulphonamides
1.2.7 Nitrofurans
1.2.8 Other
1.3 Market by Application
1.3.1 Global Urinary Tract Infection Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-Commerce
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Urinary Tract Infection Therapeutics Market Perspective (2016-2027)
2.2 Urinary Tract Infection Therapeutics Growth Trends by Regions
2.2.1 Urinary Tract Infection Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Urinary Tract Infection Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Urinary Tract Infection Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Urinary Tract Infection Therapeutics Industry Dynamic
2.3.1 Urinary Tract Infection Therapeutics Market Trends
2.3.2 Urinary Tract Infection Therapeutics Market Drivers
2.3.3 Urinary Tract Infection Therapeutics Market Challenges
2.3.4 Urinary Tract Infection Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Urinary Tract Infection Therapeutics Players by Revenue
3.1.1 Global Top Urinary Tract Infection Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Urinary Tract Infection Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Urinary Tract Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Urinary Tract Infection Therapeutics Revenue
3.4 Global Urinary Tract Infection Therapeutics Market Concentration Ratio
3.4.1 Global Urinary Tract Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urinary Tract Infection Therapeutics Revenue in 2020
3.5 Urinary Tract Infection Therapeutics Key Players Head office and Area Served
3.6 Key Players Urinary Tract Infection Therapeutics Product Solution and Service
3.7 Date of Enter into Urinary Tract Infection Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Urinary Tract Infection Therapeutics Breakdown Data by Type
4.1 Global Urinary Tract Infection Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Urinary Tract Infection Therapeutics Forecasted Market Size by Type (2022-2027)

5 Urinary Tract Infection Therapeutics Breakdown Data by Application
5.1 Global Urinary Tract Infection Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Urinary Tract Infection Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Urinary Tract Infection Therapeutics Market Size (2016-2027)
6.2 North America Urinary Tract Infection Therapeutics Market Size by Type
6.2.1 North America Urinary Tract Infection Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Urinary Tract Infection Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Urinary Tract Infection Therapeutics Market Size by Type (2016-2027)
6.3 North America Urinary Tract Infection Therapeutics Market Size by Application
6.3.1 North America Urinary Tract Infection Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Urinary Tract Infection Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Urinary Tract Infection Therapeutics Market Size by Application (2016-2027)
6.4 North America Urinary Tract Infection Therapeutics Market Size by Country
6.4.1 North America Urinary Tract Infection Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Urinary Tract Infection Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Urinary Tract Infection Therapeutics Market Size (2016-2027)
7.2 Europe Urinary Tract Infection Therapeutics Market Size by Type
7.2.1 Europe Urinary Tract Infection Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Urinary Tract Infection Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Urinary Tract Infection Therapeutics Market Size by Type (2016-2027)
7.3 Europe Urinary Tract Infection Therapeutics Market Size by Application
7.3.1 Europe Urinary Tract Infection Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Urinary Tract Infection Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Urinary Tract Infection Therapeutics Market Size by Application (2016-2027)
7.4 Europe Urinary Tract Infection Therapeutics Market Size by Country
7.4.1 Europe Urinary Tract Infection Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Urinary Tract Infection Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Urinary Tract Infection Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Type
8.2.1 Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Application
8.3.1 Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Region
8.4.1 Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Urinary Tract Infection Therapeutics Market Size (2016-2027)
9.2 Latin America Urinary Tract Infection Therapeutics Market Size by Type
9.2.1 Latin America Urinary Tract Infection Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Urinary Tract Infection Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Urinary Tract Infection Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Urinary Tract Infection Therapeutics Market Size by Application
9.3.1 Latin America Urinary Tract Infection Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Urinary Tract Infection Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Urinary Tract Infection Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Urinary Tract Infection Therapeutics Market Size by Country
9.4.1 Latin America Urinary Tract Infection Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Urinary Tract Infection Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Urinary Tract Infection Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Type
10.2.1 Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Application
10.3.1 Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Country
10.4.1 Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Urinary Tract Infection Therapeutics Introduction
11.1.4 Pfizer Revenue in Urinary Tract Infection Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Urinary Tract Infection Therapeutics Introduction
11.2.4 AstraZeneca Revenue in Urinary Tract Infection Therapeutics Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Novartis International
11.3.1 Novartis International Company Details
11.3.2 Novartis International Business Overview
11.3.3 Novartis International Urinary Tract Infection Therapeutics Introduction
11.3.4 Novartis International Revenue in Urinary Tract Infection Therapeutics Business (2016-2021)
11.3.5 Novartis International Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Urinary Tract Infection Therapeutics Introduction
11.4.4 Johnson & Johnson Revenue in Urinary Tract Infection Therapeutics Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 F. Hoffmann La Roche
11.5.1 F. Hoffmann La Roche Company Details
11.5.2 F. Hoffmann La Roche Business Overview
11.5.3 F. Hoffmann La Roche Urinary Tract Infection Therapeutics Introduction
11.5.4 F. Hoffmann La Roche Revenue in Urinary Tract Infection Therapeutics Business (2016-2021)
11.5.5 F. Hoffmann La Roche Recent Development
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Company Details
11.6.2 Teva Pharmaceutical Industries Business Overview
11.6.3 Teva Pharmaceutical Industries Urinary Tract Infection Therapeutics Introduction
11.6.4 Teva Pharmaceutical Industries Revenue in Urinary Tract Infection Therapeutics Business (2016-2021)
11.6.5 Teva Pharmaceutical Industries Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Urinary Tract Infection Therapeutics Introduction
11.7.4 Boehringer Ingelheim Revenue in Urinary Tract Infection Therapeutics Business (2016-2021)
11.7.5 Boehringer Ingelheim Recent Development
11.8 Cipla
11.8.1 Cipla Company Details
11.8.2 Cipla Business Overview
11.8.3 Cipla Urinary Tract Infection Therapeutics Introduction
11.8.4 Cipla Revenue in Urinary Tract Infection Therapeutics Business (2016-2021)
11.8.5 Cipla Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Urinary Tract Infection Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Quinolones
Table 3. Key Players of Penicillin & Combinations
Table 4. Key Players of Cephalosporin
Table 5. Key Players of Tetracycline
Table 6. Key Players of Sulphonamides
Table 7. Key Players of Nitrofurans
Table 8. Key Players of Other
Table 9. Global Urinary Tract Infection Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Urinary Tract Infection Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Urinary Tract Infection Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Urinary Tract Infection Therapeutics Market Share by Regions (2016-2021)
Table 13. Global Urinary Tract Infection Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Urinary Tract Infection Therapeutics Market Share by Regions (2022-2027)
Table 15. Urinary Tract Infection Therapeutics Market Trends
Table 16. Urinary Tract Infection Therapeutics Market Drivers
Table 17. Urinary Tract Infection Therapeutics Market Challenges
Table 18. Urinary Tract Infection Therapeutics Market Restraints
Table 19. Global Urinary Tract Infection Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Urinary Tract Infection Therapeutics Market Share by Players (2016-2021)
Table 21. Global Top Urinary Tract Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Tract Infection Therapeutics as of 2020)
Table 22. Ranking of Global Top Urinary Tract Infection Therapeutics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Urinary Tract Infection Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Urinary Tract Infection Therapeutics Product Solution and Service
Table 26. Date of Enter into Urinary Tract Infection Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Urinary Tract Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Urinary Tract Infection Therapeutics Revenue Market Share by Type (2016-2021)
Table 30. Global Urinary Tract Infection Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Urinary Tract Infection Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Urinary Tract Infection Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Urinary Tract Infection Therapeutics Revenue Market Share by Application (2016-2021)
Table 34. Global Urinary Tract Infection Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Urinary Tract Infection Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Urinary Tract Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Urinary Tract Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Urinary Tract Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Urinary Tract Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Urinary Tract Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Urinary Tract Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Urinary Tract Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Urinary Tract Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Urinary Tract Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Urinary Tract Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Urinary Tract Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Urinary Tract Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Urinary Tract Infection Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Urinary Tract Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Urinary Tract Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Urinary Tract Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Urinary Tract Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Urinary Tract Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Urinary Tract Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Urinary Tract Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Urinary Tract Infection Therapeutics Product
Table 69. Pfizer Revenue in Urinary Tract Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. AstraZeneca Company Details
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Urinary Tract Infection Therapeutics Product
Table 74. AstraZeneca Revenue in Urinary Tract Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Novartis International Company Details
Table 77. Novartis International Business Overview
Table 78. Novartis International Urinary Tract Infection Therapeutics Product
Table 79. Novartis International Revenue in Urinary Tract Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Novartis International Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Urinary Tract Infection Therapeutics Product
Table 84. Johnson & Johnson Revenue in Urinary Tract Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. F. Hoffmann La Roche Company Details
Table 87. F. Hoffmann La Roche Business Overview
Table 88. F. Hoffmann La Roche Urinary Tract Infection Therapeutics Product
Table 89. F. Hoffmann La Roche Revenue in Urinary Tract Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 90. F. Hoffmann La Roche Recent Development
Table 91. Teva Pharmaceutical Industries Company Details
Table 92. Teva Pharmaceutical Industries Business Overview
Table 93. Teva Pharmaceutical Industries Urinary Tract Infection Therapeutics Product
Table 94. Teva Pharmaceutical Industries Revenue in Urinary Tract Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Teva Pharmaceutical Industries Recent Development
Table 96. Boehringer Ingelheim Company Details
Table 97. Boehringer Ingelheim Business Overview
Table 98. Boehringer Ingelheim Urinary Tract Infection Therapeutics Product
Table 99. Boehringer Ingelheim Revenue in Urinary Tract Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Boehringer Ingelheim Recent Development
Table 101. Cipla Company Details
Table 102. Cipla Business Overview
Table 103. Cipla Revenue in Urinary Tract Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Cipla Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urinary Tract Infection Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Quinolones Features
Figure 3. Penicillin & Combinations Features
Figure 4. Cephalosporin Features
Figure 5. Tetracycline Features
Figure 6. Sulphonamides Features
Figure 7. Nitrofurans Features
Figure 8. Other Features
Figure 9. Global Urinary Tract Infection Therapeutics Market Share by Application: 2020 VS 2027
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. E-Commerce Case Studies
Figure 13. Urinary Tract Infection Therapeutics Report Years Considered
Figure 14. Global Urinary Tract Infection Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Urinary Tract Infection Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Urinary Tract Infection Therapeutics Market Share by Regions: 2020 VS 2027
Figure 17. Global Urinary Tract Infection Therapeutics Market Share by Regions (2022-2027)
Figure 18. Global Urinary Tract Infection Therapeutics Market Share by Players in 2020
Figure 19. Global Top Urinary Tract Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Tract Infection Therapeutics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Urinary Tract Infection Therapeutics Revenue in 2020
Figure 21. Global Urinary Tract Infection Therapeutics Revenue Market Share by Type (2016-2021)
Figure 22. Global Urinary Tract Infection Therapeutics Revenue Market Share by Type (2022-2027)
Figure 23. North America Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Urinary Tract Infection Therapeutics Market Share by Type (2016-2027)
Figure 25. North America Urinary Tract Infection Therapeutics Market Share by Application (2016-2027)
Figure 26. North America Urinary Tract Infection Therapeutics Market Share by Country (2016-2027)
Figure 27. United States Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Urinary Tract Infection Therapeutics Market Share by Type (2016-2027)
Figure 31. Europe Urinary Tract Infection Therapeutics Market Share by Application (2016-2027)
Figure 32. Europe Urinary Tract Infection Therapeutics Market Share by Country (2016-2027)
Figure 33. Germany Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Urinary Tract Infection Therapeutics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Urinary Tract Infection Therapeutics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Urinary Tract Infection Therapeutics Market Share by Region (2016-2027)
Figure 43. China Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Urinary Tract Infection Therapeutics Market Share by Type (2016-2027)
Figure 51. Latin America Urinary Tract Infection Therapeutics Market Share by Application (2016-2027)
Figure 52. Latin America Urinary Tract Infection Therapeutics Market Share by Country (2016-2027)
Figure 53. Mexico Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Urinary Tract Infection Therapeutics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Urinary Tract Infection Therapeutics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Urinary Tract Infection Therapeutics Market Share by Country (2016-2027)
Figure 59. Turkey Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Urinary Tract Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Pfizer Revenue Growth Rate in Urinary Tract Infection Therapeutics Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Urinary Tract Infection Therapeutics Business (2016-2021)
Figure 64. Novartis International Revenue Growth Rate in Urinary Tract Infection Therapeutics Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Urinary Tract Infection Therapeutics Business (2016-2021)
Figure 66. F. Hoffmann La Roche Revenue Growth Rate in Urinary Tract Infection Therapeutics Business (2016-2021)
Figure 67. Teva Pharmaceutical Industries Revenue Growth Rate in Urinary Tract Infection Therapeutics Business (2016-2021)
Figure 68. Boehringer Ingelheim Revenue Growth Rate in Urinary Tract Infection Therapeutics Business (2016-2021)
Figure 69. Cipla Revenue Growth Rate in Urinary Tract Infection Therapeutics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---